FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.6  |  FHIR Version n/a  User: [n/a]

900000000000526001: REPLACED BY association reference set (foundation metadata concept)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
900000000001156010 REPLACED BY association reference set (foundation metadata concept) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001157018 REPLACED BY association reference set en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)


10679 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
REPLACED BY association reference set (foundation metadata concept) Is a Historical association reference set (foundation metadata concept) true Inferred relationship Some

Members targetComponentId
dikloxacillinnatrium 62,5 mg/5 ml, suspension Dicloxacillin 12.5 mg/mL oral suspension
dikoboltedetatallergi Allergy to edetate (finding)
didanosin 100 mg, pulver till oral lösning Product containing precisely didanosine 1 milligram/1 milliliter conventional release oral solution (clinical drug)
didanosin 167 mg/förpackning, pulver Product containing precisely didanosine 1.67 milligram/1 milliliter conventional release oral solution (clinical drug)
didanosin 250 mg/förpackning, pulver Product containing precisely didanosine 2.5 milligram/1 milliliter conventional release oral solution (clinical drug)
didanosin 2 g/flaska, pulver Product containing precisely didanosine 10 milligram/1 milliliter conventional release oral solution (clinical drug)
didanosin 4 g/flaska, pulver Product containing precisely didanosine 10 milligram/1 milliliter conventional release oral solution (clinical drug)
Dideoxyinosine Product containing didanosine (medicinal product)
Dietary calorie intake Energy intake (observable entity)
medelhögt intag av natrium via kosten Dietary sodium intake normal (finding)
födoämnessubstans Edible substance (substance)
Dietary treatment and advice Dietetic procedures (procedure)
dietylpropionhydroklorid 75 mg, tablett med modifierad frisättning Product containing only amfepramone in oral dose form (medicinal product form)
dietylpropionhydroklorid 75 mg, depåtablett Product containing only amfepramone in oral dose form (medicinal product form)
Diethylpropion hydrochloride 75mg tablet Product containing only amfepramone in oral dose form (medicinal product form)
svår intubation Difficult intubation
talsvårigheter Difficulty talking
diffust storcelligt B-cellslymfom, kategori Diffuse large B cell malignant lymphoma (morphologic abnormality)
diffus unilateral subakut neuroretinit Diffuse unilateral subacute neuroretinitis
difluprednat 0,05 %, emulsion för oftalmiskt bruk Difluprednate 500 microgram/mL eye suspension
endoskop för matspjälkningssystemet Endoscope
Digoxin 38mg/vial injection Digoxin immune fab only product
Digoxin immune fab 38mg/vial powder for injection 4mL vial Digoxin immune fab only product
digoxinspecifik antikropp 38 mg, pulver till injektionsvätska, flaska Digoxin immune fab only product
antipsykotiskt medel innehållande dihydrokarbostyrilderivat Dihydrocarbostyril derivative
dihydroergotaminmesylat 1 mg/ml, injektionsvätska, lösning, ampull Product containing precisely dihydroergotamine mesilate 1 milligram/1 milliliter conventional release solution for injection (clinical drug)
dihydroergotaminmesylat 4 mg/ml, nässprej Product containing precisely dihydroergotamine mesilate 500 microgram/1 actuation conventional release nasal spray (clinical drug)
dihydroergotaminmesilatallergi Allergy to dihydroergotamine
Dihydrofolate reductase deficiency Deficiency of dihydrofolate reductase
antipsykotiskt medel innehållande dihydroindolonderivat Dihydroindolone derivative (substance)
Dilation of colon Dilation of colon
Dilation of colostomy stoma Dilation of colostomy stoma
dilitiazem 180 mg, tablett med modifierad frisättning Diltiazem only product in oral dose form
diltiazem 180 mg, depåtablett Diltiazem only product in oral dose form
dilitiazem 240 mg, tablett med modifierad frisättning Diltiazem only product in oral dose form
diltiazem 240 mg, depåtablett Diltiazem only product in oral dose form
dilitiazem 300 mg, tablett med modifierad frisättning Diltiazem only product in oral dose form
diltiazem 300 mg, depåtablett Diltiazem only product in oral dose form
dilitiazem 360 mg, tablett med modifierad frisättning Diltiazem only product in oral dose form
diltiazem 360 mg, depåtablett Diltiazem only product in oral dose form
dilitiazem 420 mg, tablett med modifierad frisättning Diltiazem only product in oral dose form
diltiazem 420 mg, depåtablett Diltiazem only product in oral dose form
diltiazemhydroklorid 420 mg, kapsel med modifierad frisättning Diltiazem only product in oral dose form
diltiazemhydroklorid 420 mg, depåkapsel Diltiazem only product in oral dose form
diltiazemhydroklorid, 5 mg/ml, lösning Product containing only diltiazem in parenteral dose form (medicinal product form)
Dimeglumine gadopentetate Product containing gadopentetic acid (medicinal product)
Dimeglumine gadopentetate Product containing gadopentetic acid (medicinal product)
gadopentetatdimeglumin 469,01 mg/ml, injektionsvätska, lösning, förfylld spruta Gadopentetic acid only product
gadopentetatdimeglumin 469,01 mg/ml, injektionsvätska, lösning, flaska Gadopentetic acid only product
Dingo dog breed Canis lupus dingo
Dinoprostone 10mg insert Dinoprostone 10 mg prolonged-release vaginal pessary
dinoproston 10 mg, vaginalinlägg Dinoprostone 10 mg prolonged-release vaginal pessary
dinoproston 10 mg/ml, infusionskoncentrat, ampull 0,5 ml Dinoprostone 10 mg/mL solution for injection
dinoproston 1 mg/ml, infusionskoncentrat, ampull 0,75 ml Dinoprostone 1 mg/mL solution for injection
Dioxygenase Dioxygenase
Dipeptide hydrolase Dipeptide hydrolase
Dipeptidyl carboxypeptidase II Dipeptidyl carboxypeptidase II (substance)
Dipeptidylpeptide hydrolase Dipeptidylpeptide hydrolase (substance)
Dipetalonema perstans Mansonella perstans (organism)
difenhydramid 2 % + zinkacetat 0,1 %, kräm för lokalt bruk Diphenhydramine hydrochloride 20 mg/mL and zinc acetate 1 mg/mL cutaneous cream
difenhydraminhydroklorid 12,5 mg/5 ml, elixir Product containing precisely diphenhydramine hydrochloride 2.5 milligram/1 milliliter conventional release oral solution (clinical drug)
difenhydraminhydroklorid 12,5 mg/5 ml, sirap Product containing precisely diphenhydramine hydrochloride 2.5 milligram/1 milliliter conventional release oral solution (clinical drug)
difenhydraminhydroklorid 6,25 mg/5 ml, sirap Diphenhydramine hydrochloride 1.25 mg/mL oral solution
Diphenhydramine hydrochloride 6.25mg/5mL syrup Diphenhydramine hydrochloride 1.25 mg/mL oral solution
extrakt specifikt för difenylmetandiisocyanat Diphenylmethane di-isocyanate
Diphtheria and tetanus double vaccination NOS Administration of diphtheria and tetanus vaccine
Diphtheria and tetanus double vaccination NOS Administration of diphtheria and tetanus vaccine
hudtest för difteri Diphtheria toxin
Diphtheria, pertussis and tetanus triple vaccination Administration of diphtheria, pertussis, and tetanus vaccine
Diphtheria, pertussis and tetanus triple vaccination NOS Administration of diphtheria, pertussis, and tetanus vaccine
Diphtheria, pertussis and tetanus triple vaccination NOS Administration of diphtheria, pertussis, and tetanus vaccine
dipivefrinhydroklorid 0,1 %, ögondroppar Dipivefrine hydrochloride 1 mg/mL eye solution
Dipivefrin hydrochloride 0.1% ophthalmic solution Dipivefrine hydrochloride 1 mg/mL eye solution
Dipivefrin hydrochloride 0.1%wv solution Dipivefrine hydrochloride 1 mg/mL eye solution
smutsig miljö Dirty environment (finding)
DAS-schema (Disability assessment schedule) World Health Organization Disability Assessment Schedule 2.0 (assessment scale)
utsöndring från suturlinje Discharge from suture line (finding)
sjukdom orsakad av Fimbriariidae Disease caused by Fimbriidae (disorder)
sjukdom orsakad av Thysanosomidae Disease caused by Thysanosomatinae (disorder)
sjukdom orsakad av överfamiljen Syngamoidea Disease due to family Syngamidae
Disease due to Cestoda Cestode infection
Disease due to Orthopoxviridae Disease due to Orthopoxvirus
Disease due to Parapoxviridae Disease due to Parapoxvirus
Disease due to Reovirus Disease due to Orthoreovirus
Disease due to Trematoda Trematode infection
Disease of biliary tract Disorder of biliary tract
Disease of endocrine gland Disorder of endocrine gonad
Disease of supporting structures of teeth Periodontal disease
Disease of teeth Tooth disorder
Disease of thymus gland, NEC Disorder of thymus gland
dinatriumedetatallergi Allergy to edetate (finding)
biverkning av dinatriumetidronat Adverse reaction to etidronic acid
dinatriumetidronatallergi Allergy to etidronic acid (finding)
allergi mot dinatriumetidronat och kalciumkarbonat Allergy to etidronic acid (finding)
biverkning av dinatriumpamidronat Adverse reaction to pamidronic acid (disorder)
dinatriumpamidronatallergi Allergy to pamidronic acid (finding)
Disodium tiludronate Product containing tiludronic acid (medicinal product)
Disopyramide phosphate 100mg capsule Product containing precisely disopyramide (as disopyramide phosphate) 100 milligram/1 each conventional release oral capsule (clinical drug)
disopyramidfosfat 100 mg, kapsel med modifierad frisättning Disopyramide only product in oral dose form
disopyramidfosfat 100 mg, tablett med modifierad frisättning Disopyramide only product in oral dose form
disopyramidfosfat 100 mg, depåkapsel Disopyramide only product in oral dose form

Start Previous Page 26 of 107 Next End


Reference Sets

Reference set descriptor

Back to Start